Validation and recalibration of OxMIV in predicting violent behaviour in patients with schizophrenia spectrum disorders by Lamsma, J, Yu, R, Fazel, S, van Amelsvoort, T, Bartels-Velthuis, A, Cahn, W, de Haan, L, Schirmbeck, F, Simons, C

Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for Psychosis by Tognin, S, Catalan, A, Aymerich, C, Richter, A, Kempton, MJ, Modinos, G, Hammoud, R, Gorostiza, I, Vassos, E, van der Gaag, M, de Haan, L, Nelson, B, Riecher-Rössler, A, Bressan, R, Barrantes-Vidal, N, Krebs, M, Nordentoft, M, Ruhrmann, S, Sachs, G, Rutten, BPF, Valmaggia, L, McGuire, P

Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN by Slot, MIE, Urquijo Castro, MF, Winter - van Rossum, I, van Hell, HH, Dwyer, D, Dazzan, P, Maat, A, De Haan, L, Crespo-Facorro, B, Glenthøj, BY, Lawrie, SM, McDonald, C, Gruber, O, van Amelsvoort, T, Arango, C, Kircher, T, Nelson, B, Galderisi, S, Weiser, M, Sachs, G, Kirschner, M, Fleischhacker, WW, McGuire, P, Koutsouleris, N

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis by Pollak, TA, Kempton, MJ, Iyegbe, C, Vincent, A, Irani, SR, Coutinho, E, Menassa, DA, Jacobson, L, de Haan, L, Ruhrmann, S, Sachs, G, David, AS, Riecher-Rössler, A, Krebs, M-O, Amminger, P, Glenthøj, B, Barrantes-Vidal, N, Van Os, J, Rutten, BPF, Bressan, RA, van der Gaag, M, Yolken, R, Hotopf, M, Valmaggia, L, Stone, J, David, AS, EUGEI High Risk Study, McGuire, P